Table 1 (abstract P076). Clinical efficacy in Indian subset from REPROVE and RECLAIM studies
From: 39th International Symposium on Intensive Care and Emergency Medicine
Clinical Cure at TOC (%) in CE population | Clinical Cure at TOC in cMITT(%) | ||
|---|---|---|---|
CAZ‑AVI | Meropenem | CAZ‑AVI | Meropenem |
REPROVE study | |||
 22/25 (88.0) | 27/35 (77.1) | 25/31 (80.6) | 28/39 (71.8) |
RECLAIM study | |||
 45/46 (97.8) | 42/44 (95.5) | 50/56 (89.3) | 50/59 (84.7) |